HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qizhi Yao Selected Research

ginkgolide A

11/2011Ginkgolide A-gold nanoparticles inhibit vascular smooth muscle proliferation and migration in vitro and reduce neointimal hyperplasia in a mouse model.
10/2006Ginkgolide A attenuates homocysteine-induced endothelial dysfunction in porcine coronary arteries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qizhi Yao Research Topics

Disease

53Neoplasms (Cancer)
08/2021 - 06/2004
39Pancreatic Neoplasms (Pancreatic Cancer)
08/2021 - 06/2004
25Cardiovascular Diseases (Cardiovascular Disease)
03/2016 - 10/2002
22Atherosclerosis
01/2013 - 07/2004
14Inflammation (Inflammations)
01/2013 - 07/2004
12Vascular Diseases (Vascular Disease)
01/2013 - 02/2005
10Neoplasm Metastasis (Metastasis)
09/2013 - 11/2006
9Adenocarcinoma
01/2021 - 11/2004
6Hypertension (High Blood Pressure)
01/2014 - 05/2003
6Thrombosis (Thrombus)
02/2012 - 05/2004
5HIV Infections (HIV Infection)
01/2014 - 10/2002
5Insulin Resistance
01/2013 - 04/2005
4Obesity
01/2013 - 04/2005
4Hyperplasia
11/2011 - 05/2004
4Vascular System Injuries
11/2011 - 12/2004
4Human Influenza (Influenza)
06/2009 - 01/2003
4Carcinogenesis
01/2009 - 02/2005
3Cholangiocarcinoma
02/2015 - 08/2011
3Mitochondrial Diseases (Mitochondrial Disease)
07/2010 - 07/2007
3Infections
06/2008 - 03/2005
3Hypoxia (Hypoxemia)
04/2008 - 07/2007
2Gout
07/2016 - 11/2013
2Hyperuricemia
07/2016 - 11/2013
2Autoimmune Diseases (Autoimmune Disease)
02/2014 - 02/2012
2Diabetes Mellitus
01/2014 - 04/2005
2Autistic Disorder (Autism)
01/2012 - 04/2010
2Carcinoma (Carcinomatosis)
09/2010 - 12/2009
2Necrosis
07/2010 - 10/2002
2Nervous System Diseases (Neurological Disorders)
05/2010 - 03/2005
2Colorectal Neoplasms (Colorectal Cancer)
04/2009 - 01/2007
2Hyperhomocysteinemia
01/2009 - 12/2004
2Aortic Aneurysm (Aneurysm, Aortic)
11/2006 - 07/2006
2Atherosclerotic Plaque (Atheroma)
06/2005 - 01/2005
2Coronary Artery Disease (Coronary Atherosclerosis)
06/2005 - 11/2003
1COVID-19
01/2022
1Critical Illness (Critically Ill)
01/2022
1Sepsis (Septicemia)
01/2022

Drug/Important Bio-Agent (IBA)

15CytokinesIBA
01/2014 - 04/2005
10MesothelinIBA
08/2021 - 03/2005
9Proteins (Proteins, Gene)FDA Link
08/2021 - 02/2005
8MicroRNAs (MicroRNA)IBA
08/2021 - 04/2009
7AntioxidantsIBA
03/2016 - 12/2004
7Messenger RNA (mRNA)IBA
11/2008 - 06/2004
6Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2008
6Cyclophilin AIBA
02/2015 - 02/2005
6ResistinIBA
01/2013 - 04/2005
6HIV Protease InhibitorsIBA
11/2011 - 10/2002
6Ritonavir (Norvir)FDA Link
11/2011 - 10/2002
5Pharmaceutical PreparationsIBA
03/2016 - 05/2009
5zinc-binding protein (zinc binding protein)IBA
09/2013 - 11/2007
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2010 - 11/2004
5C-Reactive ProteinIBA
03/2008 - 08/2005
5HomocysteineIBA
10/2006 - 11/2003
4ThymosinIBA
09/2013 - 03/2005
4Interleukin-6 (Interleukin 6)IBA
01/2013 - 06/2007
4Membrane Glycoproteins (Membrane Glycoprotein)IBA
04/2011 - 11/2008
4Small Interfering RNA (siRNA)IBA
02/2010 - 05/2008
4Somatostatin Receptors (Somatostatin Receptor)IBA
11/2008 - 06/2004
4Biological ProductsIBA
02/2008 - 02/2005
3DNA (Deoxyribonucleic Acid)IBA
08/2021 - 04/2010
3GemcitabineFDA Link
01/2019 - 04/2011
3EnzymesIBA
11/2013 - 10/2007
3Transcription Factors (Transcription Factor)IBA
11/2013 - 10/2007
3ZincIBA
09/2013 - 11/2007
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
11/2008 - 06/2004
3NeuropilinsIBA
04/2008 - 11/2004
3PhosphoproteinsIBA
03/2008 - 05/2006
3VaccinesIBA
02/2008 - 09/2003
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2006 - 03/2005
3somatostatin receptor 2IBA
10/2005 - 06/2004
2Untranslated RNA (Noncoding RNA)IBA
08/2021 - 08/2011
2Peptides (Polypeptides)IBA
08/2021 - 01/2005
2AntigensIBA
06/2020 - 03/2005
2Uric Acid (Urate)IBA
07/2016 - 11/2013
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2015 - 04/2011
2ginkgolide AIBA
11/2011 - 10/2006
2Masoprocol (Actinex)FDA Link
11/2011 - 05/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2010 - 05/2008
2RNA (Ribonucleic Acid)IBA
04/2010 - 06/2004
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
03/2010 - 11/2008
2thymosin beta(10)IBA
12/2009 - 04/2006
2Hemagglutinins (Hemagglutinin)IBA
06/2009 - 08/2004
2Tumor Biomarkers (Tumor Markers)IBA
11/2008 - 11/2006
2Tyrosine (L-Tyrosine)FDA Link
11/2008 - 06/2006
2CholesterolIBA
03/2008 - 07/2007
2Scavenger Receptors (Scavenger Receptor)IBA
07/2007 - 11/2004
2Protease Inhibitors (Protease Inhibitor)IBA
07/2007 - 04/2007
2NeuropeptidesIBA
08/2006 - 03/2005
2DefensinsIBA
02/2006 - 01/2005
2Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
01/2006 - 09/2005
2Heparin (Liquaemin)FDA LinkGeneric
06/2004 - 05/2004
2Polytetrafluoroethylene (Teflon)FDA Link
06/2004 - 05/2004
1BuffersIBA
01/2022
1FibrinIBA
01/2022
1fibrin fragment D (D-dimer)IBA
01/2022

Therapy/Procedure

20Therapeutics
01/2014 - 10/2002
7Drug Therapy (Chemotherapy)
08/2011 - 10/2007
5Highly Active Antiretroviral Therapy (HAART)
11/2011 - 04/2007
3Immunotherapy
04/2009 - 11/2004
2Thrombectomy
04/2007 - 04/2007